These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 34348576)

  • 1. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
    Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
    Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vagus nerve stimulation on emergency department utilization in children with drug-resistant epilepsy: a retrospective cohort study.
    Muthiah N; Reecher HM; Abel TJ
    J Neurosurg Pediatr; 2024 Sep; 34(3):260-267. PubMed ID: 38905712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagus nerve stimulation for partial seizures.
    Panebianco M; Rigby A; Weston J; Marson AG
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD002896. PubMed ID: 25835947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
    Chambers A; Bowen JM
    Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model.
    Chan HY; Wijnen BFM; Majoie MHJM; Evers SMAA; Hiligsmann M
    Epilepsia; 2022 Mar; 63(3):641-651. PubMed ID: 34967942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis.
    Batson S; Shankar R; Conry J; Boggs J; Radtke R; Mitchell S; Barion F; Murphy J; Danielson V
    J Neurol; 2022 Jun; 269(6):2874-2891. PubMed ID: 35034187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of vagus nerve stimulation and antiseizure medication.
    Winter Y; Sandner K; Glaser M; Ciolac D; Sauer V; Ziebart A; Karakoyun A; Chiosa V; Saryyeva A; Krauss J; Ringel F; Groppa S
    J Neurol; 2023 Oct; 270(10):4978-4984. PubMed ID: 37368131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
    Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
    Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
    de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
    Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
    Zhang L; Hall M; Lam SK
    Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.
    Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ
    Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
    Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
    Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
    Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
    Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.
    Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y
    Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.